Covalon Technologies Ltd Stock Toronto S.E.
Equities
COV
CA22282D3022
Biotechnology & Medical Research
Sales 2022 | 18.15M 13.2M | Sales 2023 | 26.6M 19.34M | Capitalization | 37M 26.91M |
---|---|---|---|---|---|
Net income 2022 | -9M -6.54M | Net income 2023 | -4M -2.91M | EV / Sales 2022 | 2.65 x |
Net cash position 2022 | 13.26M 9.65M | Net cash position 2023 | 7.23M 5.26M | EV / Sales 2023 | 1.12 x |
P/E ratio 2022 |
-6.44
x | P/E ratio 2023 |
-8.33
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 47.53% |
Latest transcript on Covalon Technologies Ltd
Managers | Title | Age | Since |
---|---|---|---|
Valerio DiTizio
FOU | Founder | - | 04-04-27 |
Amir Boloor
CHM | Chairman | - | 20-04-26 |
Kim Crooks
COO | Chief Operating Officer | - | 07-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Ronald Smith
BRD | Director/Board Member | 73 | 19-03-17 |
Abe Schwartz
BRD | Director/Board Member | - | 08-03-06 |
Martin Goldfarb
BRD | Director/Board Member | - | 20-04-22 |
1st Jan change | Capi. | |
---|---|---|
-1.51% | 41.35B | |
+42.15% | 40.38B | |
+1.96% | 39.05B | |
-14.19% | 26.67B | |
+1.82% | 24.07B | |
-24.62% | 18.36B | |
-3.97% | 11.68B | |
+21.36% | 11.6B | |
+8.36% | 11.15B |